). In the validation cohort, these 3 models performed better than other available equations, but had wide limits of agreement, particularly in older individuals with shorter stature, higher heart rate, and lower maximum voluntary ventilation. CONCLUSIONS: We developed more accurate formulae to predict resting V O 2 in subjects with respiratory symptoms; however, equations had wide limits of agreement, particularly in certain groups of subjects. Arterial blood gases and spirometric variables did not significantly improve the predictive equations.
Introduction
The available equations to estimate oxygen consumption (V O 2 ) were obtained from selected populations (eg, children with congenital heart diseases) that commonly differ from the patients encountered in clinical practice (Table 1 ). More importantly, the estimates of resting V O 2 by the available formulae are inaccurate when compared with the V O 2 directly measured either by the breath-tobreath methodology or Douglas bag technique combined with mass spectrometry. 1 Due to these limitations, investigators have questioned the value of estimating V O 2 and supported its direct measurement. 2 Equations to estimate V O 2 have not been systematically studied in patients with lung diseases or respiratory symptoms. It is possible that arterial blood gases and spirometric parameters may be of value to better predict the resting V O 2 in patients with respiratory symptoms or diseases. We hypothesize that the estimation of V O 2 in patients with respiratory symptoms or diseases is inaccurate and that the predictive equations can be improved by adding parameters obtained from arterial blood gases and/or pulmonary function tests.
Methods

Subject Selection and Study Design
The research protocol was approved by the Cleveland Clinic institutional review board (study . Written informed consent was waived. We included consecutive unique subjects who underwent cardiopulmonary exercise testing at the Pulmonary Function Test Laboratory of the Respiratory Institute, Cleveland Clinic, between October 2010 and September 2013. Cardiopulmonary exercise testing was ordered at the discretion of the treating physicians and was performed according to the American Thoracic Society/American College of Chest Physician recommendations. 3 Common reasons for ordering the test included unexplained dyspnea and preoperative evaluation to better estimate the risk of surgery in subjects with lung diseases. We have not included patients with cardiovascular diseases because these individuals are tested by the Heart and Vascular Institute and are not captured in our database. Similarly, we did not include patients with known pulmonary hypertension, given that patients with this condition rarely undergo cardiopulmonary exercise testing at our laboratory.
Immediately before each cardiopulmonary exercise test, we measured height and weight, which were then used to calculate body surface area (BSA) by the equation of Du Bois et al 4 :
Furthermore, we recorded information on smoking status, type and time of last meal, medications, reason for the test, and need for supplemental oxygen therapy. We measured blood pressure and heart rate. Immediately before the V O 2 determination and per protocol, we performed spirometry following American Thoracic Society/European Respiratory Society recommendations 5 and obtained arterial blood gases from the radial artery. We later collected data on the type and severity of lung disease, serum thyroid-stimulating hormone concentration, and echocardiographic measurements. We graded severity of air flow limitation following the recommendations of the Global Initiative for Chronic Obstructive Lung disease. 6 Restrictive lung disease was considered present when spirometry showed FEV 1 over forced vital capacity (FEV 1 /FVC) Ն 0.7 and the total lung capacity was less than 80% of predicted. 7 In case of unspecific spirometric findings or overlap (obstructive and restrictive disease), we reported the predominant ventilatory defect, based on a comprehensive evaluation by the authors (ART and AA).
V O 2 Determination
Subjects were told to continue taking all medications and only eat a light meal on the day of the test (Ͼ 2 h before the test). All examinations were performed by experienced respiratory therapists. No sedatives were given. Room temperature was maintained at 70°F. After an acclimatization phase, we measured V O 2 over a period of 5 min at rest in sitting position. V O 2 was determined using the Ultima CardiO 2 gas exchange analysis system (MGC Diagnostics, Saint Paul, Minnesota), which is commercially available and uses breath-by-breath testing methodology. All subjects breathed spontaneously using an adequately sized 7450 series V2 face mask (Hans Rudolph, Inc, Shawnee, Kansas) held in place by head gear. We used a polycarbonate plastic adapter (Hans Rudolph, Inc) to connect the preVent flow sensor (MGC Diagnostics) to the mask. We performed flow and gas calibration before each test. All pertinent information was uploaded to an Excel database.
In the event the subject was on continuous O 2 therapy, we provided supplementary O 2 with a F IO 2 of 30%, using a 30% O 2 tank and a 30 L nondiffusing gas bag made of multilayer polyethylene thermoplastic laminate with a layer of aluminum foil at the center (Hans Rudolph, Inc). Corrugated tubing connected the 3-way stopcock attached to the bag and the mouthpiece.
Formulae for Estimating Resting V O 2
For the estimation of resting V O 2 , we used the formulae by Bergstra et al 8 
Statistical Analysis
Continuous data are presented as mean Ϯ SD or median (interquartile range) where appropriate. Categorical data are summarized as discrete values and percentages (n [%]). The data were randomly separated into training and testing cohorts at a ratio of 3:1. Although we randomly divided these 2 groups, it was expected that some variables would be statistically different between them, a fact that tests the V O 2 predictive equations more rigorously. The training data were used to build the linear regression model. Univariate linear regression analyses were performed on all predetermined independent variables and the outcome of interest, that is, resting V O 2 (mL/min). We performed correlation analysis of the predictors to avoid multicollinearity in multivariate regression models. The algorithm by Kuhn 15 was applied to find the minimal set of predictors, and we excluded variables that were highly correlated (correlation value Ͼ 0.8). The remaining predictors whose P values were Ͻ .10 in the univariate linear regression analyses were used for building the multivariate linear regression models. Stepwise variable selection procedure using Akaike information criterion 16 was applied to identify the final multivariate models. Nonlinearity and interactions were explored in the model building process.
We built 3 multivariate models from the training dataset, as different sets of variables may be available to healthcare providers. The 3 models as well as 7 previous models in the literature were assessed in the testing (validation) dataset. The concordance correlation coefficients (CCC) between estimated and measured V O 2 determinations 17 were calculated to evaluate the performance among all models. CCC is a standardized coefficient that contains a measurement of precision (Pearson correlation coefficient) and accuracy (bias correction factor). It ranges between Ϫ1 and 1 (1 represents perfect agreement). We calculated the coefficient of variation (100 ϫ SD/mean) as well as the median and interquartile range of the absolute and percentage (absolute difference ϫ 100/measured V O 2 ) difference between the measured and estimated resting V O 2 . Bland-Altman methodology 18 was used to plot the percentage difference between measured and estimated V O 2 against the measured V O 2 (accepted standard). 19 The mean difference and 95% limit of agreement are reported when appropriate. 18 All P values are 2-tailed, and a value of Ͻ .05 was considered significant. SPSS 20 (SPSS, Chicago, Illinois), MedCalc (Ostend, Belgium), and R studio software were employed for the analyses (R Project, Vienna, Austria). 
Overall Characteristics of the Study Population
We included 450 subjects, of whom 336 subjects formed part of the training cohort (used to build the lineal regression models) and 114 of the validation group (used to test the proposed and available formulae to estimate V O 2 ). Characteristics of the training and validation cohort are presented in Table 2 .
Building a Model to Predict V O 2
We determined the measured V O 2 and V O 2 /kg for a large number of variables of interest (Table 3) . On occasion, only V O 2 or V O 2 /kg were significant between groups; however, we only focused in predicting the measured absolute V O 2 rather than V O 2 /kg, because performing regression analysis on indexed values that are then transformed to absolute values can lead to errors due to regression to the mean. 8 We identified several predictors that had a P value Ͻ .10 on univariate linear regression analysis (gender, height, weight, BSA, smoking status, heart rate, breathing frequency, F IO 2 , hemoglobin concentration, O 2 content, lactic acid concentration, FVC, FEV 1 , FEV 1 /FVC, maximum voluntary ventilation [MVV], severity of obstructive or restrictive lung disease, and minute ventilation).
After correlation analyses, we removed arterial oxygen content, FEV 1 % of predicted, FVC percentage of predicted, and measured MVV. We kept BSA instead of height and/or weight, because BSA was preferentially selected by our models.
Our 
An alternative model was constructed using minute ventilation, a value obtained from the breath-to-breath analysis system (model 3). In this case, resting V O 2 ϭ Ϫ142.92 ϩ 0.52 ϫ heart rate (beats/min) ϩ 126.84 ϫ BSA (m 2 ) ϩ 14.68 ϫ minute ventilation (L). The R 2 for this model was 0.68 (adjusted R 2 : 0.68).
Comparison of the New Models to Predict V O 2 with Established Ones
In the validation cohort, we compared our 3 models with 7 other available formulae that estimate resting V O 2 (Table 4) . We used the CCC, coefficient of variation, absolute and percentage difference, as well as Bland-Altman analysis. The CCCs of our 3 models (particularly models 1 and 3) were higher than others. The coefficients of variation as wells as the percentage differences between measured and estimated V O 2 were lower for our models as well as the formulae by Bergstra et al, 8 Lundell et al, 13 and Wessel et al 14 Bland-Altman analyses for model 1 and the formulae by Bergstra et al, 8 Lundell et al, 13 and Wessel et al 14 are presented in Figure 1 . All plots showed a proportional difference, because they tend to overestimate lower V O 2 values and underestimate higher V O 2 determinations.
Characteristics of the Subjects Who Had > 25% Difference Between Estimated (Model 1) and Measured V O 2
Subjects who had Ն 25% difference between the measured and estimated resting V O 2 (model 1) were older (63 Ϯ 15 vs 50 Ϯ 18 y, P ϭ .004) and had shorter stature (163 Ϯ 10 vs 169 Ϯ 10 cm, P ϭ .02), lower measured MVV (82 Ϯ 40 vs 110 Ϯ 44 L, P ϭ .02), and higher heart rate (91 Ϯ 17 vs 81 Ϯ 14 beats/min, P ϭ .07) than those with a small difference. No arterial blood gas or spirometric differences were noted between these groups. The addition of age or log e (age), height, or MVV to our models did not improve the R 2 .
Discussion
In the present study, we noted a poor accuracy between the measured and estimated V O 2 in subjects with respiratory symptoms. Hence, we assessed the impact of a variety of factors on the measured V O 2 and developed 3 models that included a selection of respiratory parameters (F IO 2 , breathing frequency, or minute ventilation) that unexpectedly did not incorporate arterial blood gas or spirometric determinations. Even though our models performed better than other formulae in predicting V O 2 in this particular population, the limits of agreement were wide, particularly in older individuals with shorter stature, higher heart rate, and lower MVV.
Oxygen consumption is an essential measurement for the calculation of cardiac output by the accepted standard, Fick methodology; however, in the cardiac catheterization laboratories, V O 2 is commonly estimated instead of measured, given that it is time-consuming and requires especial equipment (ie, breath-by-breath metabolic cart analysis) and expertise. As a result, in clinical practice, V O 2 is often estimated by a variety of equations that generally use a combination of variables such as BSA, age, gender, and heart rate. 8, 9, 11 Several investigators have noted poor agreement between measured and estimated V O 2 in different groups of adult patients. 1, 2, [20] [21] [22] [23] [24] In large part, this is due to marked differences between the population in which the formulae were derived and the characteristics of the cohort studied. In fact, many factors can affect the measured V O 2 including age, 8, 11 gender, 8, 11, 13, 23, 25 BSA, 8, 11, 13, 23, 25 fat-free mass, heart rate, 11, 13, 25 degree of sedation, 9,14,25 temperature (of the patient and environment), 25 time of day, prior food intake, level of activity, 25 and position. 9 Although several parameters were associated with resting V O 2 in multivariate models, only BSA, gender, heart rate, breathing frequency, need for supplementary O 2 , and minute ventilation were significant predictors. Because V O 2 directly depends on the body size of a person, BSA is the most commonly used variable in available equations. In fact, BSA was used in all but two 10, 12 of the tested formulae for resting V O 2 estimation. The formulae proposed by Krovetz et al 10 uses height and weight and the equation by Lindahl 12 only weight. In our study, BSA area was selected for our models instead of height and/or weight.
Men have a higher V O 2 than women, given the higher fat-free mass. Therefore, gender was selected in three 8, 11, 13 out of the 7 formulae tested. Similarly, heart rate, an indicator of stress that changes in relation to the metabolic rate, was used in 2 out of the 7 equations. Breathing frequency, need for supplementary O 2 , and minute ventilation were not included in prior equations that estimate resting V O 2 , likely because these parameters are more applicable to our particular group of subjects with respiratory symptoms. It is important to consider that, immediately before cardiopulmonary exercise testing or cardiac catheterization, patients are not in a strictly basal state as they may be anxious, a condition that may lead to an increase in minute ventilation, heart rate, and V O 2 . 2 Age, as log e (age), was used in two 8, 11 formulae, obtained in cohorts that included children and adults. In the present study, we also noted that age was indirectly associated with V O 2 /kg; however, age or log e (age) was not selected in any of our 3 multivariate models that predict V O 2 . Furthermore, specific determinations of general value in pulmonary patients, that is, arterial blood gases or spirometry, did not add prognostic value.
The 3 models presented in our study had wide limits of agreement and were not able to explain more than 68% of the V O 2 variance. In addition, adding parameters obtained from arterial blood gases and/or pulmonary function tests did not improve the performance of the equations to predict V O 2 , a fact that negated our working hypothesis. This could reflect that F IO 2 (model 1), breathing frequency (model 2), and minute ventilation (model 3) are better and probably more comprehensive estimates of V O 2 than other more specific parameters obtained from spirometry or arterial blood gases.
In general, the formulae that estimate V O 2 are associated with systematic error as they tend to underestimate the higher V O 2 values and overestimate the lower determinations. This is relevant because differences between the measured and estimated V O 2 of Ն 25% may result in large errors in the determination of Q and calculation of dependent variables. In our study, we observed that the estimated V O 2 was mostly inaccurate in older individuals with shorter stature, higher heart rate, and lower MVV. The reasons for the greater discrepancies between measured and estimated V O 2 in this group of subjects remain unclear. A potential explanation include a nonlinear relationship between V O 2 and age, height, MVV, or heart rate. It is possible that, due to the limited number of subjects at the end of these spectra, our model was not sensitive enough to detect this nonlinear association. Future studies testing particular subgroups of subjects may be of value to refine our equations.
The V O 2 variance not captured in our study might be explained by variables that we did not measure, such as fat-free mass, core temperature, and general level of activity. It is also likely that there are unknown factors that might be responsible for the V O 2 variation. Given that V O 2 varies greatly and estimations are still generally inaccurate, we support the direct measurement of V O 2 instead of its estimation. It is also important to point out that V O 2 varies in patients with sepsis, 26, 27 hypovolemia, 28 pulmonary hypertension, 29 congestive heart failure, 30 or COPD, 31 both at baseline and with treatment. 32 Thus, current formulae are likely inaccurate in these groups of patients.
Our study has limitations: (1) the results are only applicable to nonsedated patients at rest in a sitting position with respiratory symptoms and/or conditions, (2) body temperature and fat-free mass were not measured at the time of V O 2 determination, and (3) we cannot exclude potential bias due to the retrospective nature of our study; however, cardiopulmonary exercise studies were performed by a few experienced respiratory therapists under similar conditions and following a prespecified protocol. Notwithstanding these limitations, our study emphasizes the lack of accuracy of formulae to predict V O 2 and is the first to generate different models to estimate resting V O 2 in subjects with respiratory symptoms or conditions, and to compare them with available formulae.
Conclusions
We developed more accurate formulae to predict oxygen consumption in the group of subjects who underwent cardiopulmonary exercise testing for respiratory symptoms and/or conditions. Arterial blood gases and spirometric variables did not significantly improve the predictive equations.
